Aptamer Group opens new state-of-the-art laboratories
Drug Discovery Today
NOVEMBER 28, 2022
The new facilities will support the increased demand for Optimer technology.
Sat.Nov 26, 2022 - Fri.Dec 02, 2022
113 
Talk of the Towne Episode 05: Diversity in research with Allison Kalloo
Antidote
NOVEMBER 30, 2022
Antidote’s podcast, Talk of the Towne , focuses on the ultimate sweet spot: that special place where science and patients converge. Our host, Dr. Rich Towne, was trained in pharmacy and currently works in Clinical Informatics at Antidote. In each episode, Rich welcomes a new guest from an Antidote partner organization, and takes an in-depth look at a particular area of interest, zeroing in on the story that Antidote's data is telling about how best to connect patients and research.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels News Roundup, November 2022: Mark Cuban vs. Elon Musk, Lessons from Semglee, Gen Z vs. Pharmacy Careers, 340B Transparency, and I ? the 90s
Drug Channels
NOVEMBER 29, 2022
I hope everyone enjoyed the Thanksgiving holiday! Now that you’ve stretched your stomach, stretch your mind with some food for thought. In this issue: Mark Cuban schools Elon Musk on PBMs Market access lessons from Semglee Gen Z rejects the pharmacy career path A potent call for 340B transparency Plus, get ready to love the ‘90s again! P.S. Join my more than 34,000 LinkedIn followers for daily links to neat stuff.
Celebrating 35 Years of Innovation and Impact: An Interview Series
Cytel
DECEMBER 2, 2022
For 35 years , Cytel’s scientific rigor and operational excellence have enabled biotech and pharmaceutical companies to navigate uncertainty, prove value, and make evidence-based decisions with confidence. To celebrate this milestone, we invited Cytel’s Co-Founders, Nitin Patel and Cyrus Mehta, and CEO, Joshua Schultz, to offer their reflections on Cytel’s beginnings, its innovations in technology and statistical strategy over nearly four decades, and predictions for the future of the industry.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Q4 2022 Newsletter – Deuterated Metabolites
Metabolite Tales Blog
DECEMBER 2, 2022
Hypha’s Q4 2022 newsletter – synthesis of deuterated metabolites In our Q4 2022 newsletter we look at how Hypha make deuterated metabolites, illustrated using case studies where biotransformation and late-stage chemical synthesis techniques were employed. Sign up at the bottom of the page in the link here to receive our quarterly newsletter by email Read newsletter Biotransformation of deuterated flurbiprofen to a deuterated form of the main human metabolite using microbes and recomb
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
More Trending
Spot-on genomics: top tech to watch in 2023
sptlabtech
DECEMBER 2, 2022
We sat down with Paul Lomax, Head of Genomics at SPT Labtech, to find out how exciting new technological developments have opened up opportunities for widespread innovation. In this interview, Paul touches on the history and current state of play of automation technologies for genomics before giving us a glimpse into what we can look forward to in the near future.
How Open Targets is using Artificial Intelligence and Machine Learning to identify and prioritise drug targets
The Open Targets Blog
DECEMBER 2, 2022
Artificial Intelligence and Machine Learning (AI/ML) have applications across all areas of drug discovery and development. At Open Targets, our main focus is target identification and prioritisation, and a 2017 analysis by Enrico Ferrero shows that the data linking genes and diseases in the Open Targets Platform is already sufficient to effectively predict novel targets for which therapies are actively being pursued or are already on the market.
Which pharmaceutical companies have the most drug patents in Denmark?
Drug Patent Watch
DECEMBER 2, 2022
This chart shows the pharmaceutical companies with the most patents in Denmark. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Denmark? appeared first on DrugPatentWatch - Make Better Decisions.
Tryptophan Fluorescence: nature’s probe | BMG LABTECH
BMG Labtech
DECEMBER 1, 2022
Proteins are indispensable molecular catalysts of biological reactions and play important structural roles in cells. The way they fold or unfold reveals crucial information about their biological activity.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Developing a Channel Strategy that Optimizes Gross-to-Net
Drug Channels
DECEMBER 1, 2022
Today’s guest post comes from Deepak Thomas, Founder and CEO of PHIL Inc. Deepak explains how a manufacturer’s net revenues are affected when that manufacturer helps patients access, afford, and adhere to medication therapy. He provides three suggestions for building a channel strategy to optimize gross-to-net while also improving clinical, financial, and operational outcomes.
Your Guide to sIRB Mandates
Advarra
DECEMBER 1, 2022
In the past several years, Health and Human Services (HHS) Office of Human Research Protections (OHRP), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH) have announced and/or implemented new regulations to address the challenges of conducting clinical trials involving multiple research sites. Chief among these requirements is the use of a designated single institutional review board (sIRB) for multisite research (also known as a central IRB [cIRB]).
New patent for Belcher drug EPINEPHRINE
Drug Patent Watch
DECEMBER 2, 2022
Annual Drug Patent Expirations for EPINEPHRINE Epinephrine is a drug marketed by Armstrong Pharms, Belcher, Intl Medication Sys, Am Regent, Hospira, and Teva Pharms Usa and, and is included in…. The post New patent for Belcher drug EPINEPHRINE appeared first on DrugPatentWatch - Make Better Decisions.
6 Common Types of Psoriasis and Their Symptoms
Olympian Clinical Research
DECEMBER 1, 2022
Psoriasis is a chronic, autoimmune skin condition. By speeding up the growth cycle of skin cells, psoriasis creates thick, red patches on the skin that are frequently covered in white scale-like tissue. Various types of psoriasis affect nearly 7.5 million US adults. . The type of psoriasis you experience can influence the symptoms and complications associated with your condition as well as the treatment plan that is right for you.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
In Silico in Action: A Case Study in Relapsing Remitting Multiple Sclerosis
The Premier Consulting Blog
NOVEMBER 30, 2022
Computer modeling and simulation of humans, both healthy and with diseases, is a powerful tool. It can augment preclinical and clinical research through mechanistic and predictive investigations that would otherwise be impossible. In recent years, regulatory agencies have begun to accept evidence obtained through modeling and simulation, and in silico clinical trials have emerged as an important approach for virtual testing of pharmacological therapies and medical devices.
Why Keep HIPAA Separate from the Informed Consent Form
Advarra
DECEMBER 1, 2022
The research informed consent form (ICF) is designed to provide prospective participants with the necessary information to make an informed decision about whether to participate in a clinical trial. Frequently included in the informed consent is an institution’s Health Insurance Portability and Accountability Act (HIPAA) statement, which informs participants of how their protected health information (PHI) may be used or disclosed by covered entities for research purposes.
New patent for Pacira Pharms drug EXPAREL
Drug Patent Watch
DECEMBER 2, 2022
Annual Drug Patent Expirations for EXPAREL Exparel is a drug marketed by Pacira Pharms Inc and is included in one NDA. It is available from one supplier. There are eight…. The post New patent for Pacira Pharms drug EXPAREL appeared first on DrugPatentWatch - Make Better Decisions.
Applications of Genetically Engineered Organoids and Cell Lines
Crown Bioscience
NOVEMBER 30, 2022
This post explores applications of genetically engineered organoids and cell lines to expand and accelerate anti-cancer drug discovery and development. We first provide a brief overview of two major methods that are used to develop engineered organoids/cell lines (i.e., lentiviral transduction and PiggyBac), followed by typical workflows for generating these models.
Deliver Fast, Flexible Clinical Trial Insights with Spotfire
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Bayesian Adaptive Clinical Trial Designs: INLA vs. MCMC
Cytel
NOVEMBER 29, 2022
Bayesian methods have continuously played a key role in transforming clinical research in therapeutic areas such as oncology and rare diseases, and in addressing clinical development challenges for COVID-19 drugs, devices, and biologics. From early-phase trials to late-phase development, utilizing Bayesian tools can expedite and/or de-risk trials, even when used to augment a Frequentist framework.
Protein Assays | BMG LABTECH
BMG Labtech
NOVEMBER 29, 2022
What are proteins? Next to carbohydrates, lipids and nucleic acids, proteins are one of the main macromolecule building blocks of life. On a molecular basis, they can be described as complex polymers of amino acids, connected via a peptide bond backbone (fig.1). There are 20 different types of amino acids available as possible residues of individual subunits of a protein.
New patent for Aveo Pharms drug FOTIVDA
Drug Patent Watch
DECEMBER 2, 2022
Annual Drug Patent Expirations for FOTIVDA Fotivda is a drug marketed by Aveo Pharms and is included in one NDA. It is available from one supplier. There are two patents…. The post New patent for Aveo Pharms drug FOTIVDA appeared first on DrugPatentWatch - Make Better Decisions.
Regulatory Trends in Cell and Gene Therapies
Advarra
NOVEMBER 29, 2022
The field of cell and gene therapies (CGT) is constantly evolving, and there has been significant progress in this area of research. However, despite the promise of these therapies, the regulations governing them lag the science, which in turn hinders the clinical translation of these novel medicines. There have been recent signals indicating the Food and Drug Administration (FDA) plans to provide greater support for CGT, addressing key issues continuing to impede their development.
Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
SMR Meeting: Recent Trends in Medicinal Chemistry and Enabling Technologies
Zobio
NOVEMBER 28, 2022
In person On 8th December 2022, the Society for Medicines Research and the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry were jointly hosting a 1-day meeting in London on Recent Trends in Medicinal Chemistry and Enabling Technologies. The meeting was a combination of medicinal chemistry, chemistry-based drug discovery enabling technologies and.
Federal Judge In California Cabins Innovator Liability
Drug & Device Law
DECEMBER 2, 2022
We wrote recently that California’s courts have never met a case they did not like. We were speaking somewhat tongue in cheek of course, but still California remains a destination for litigation tourists trying to take advantage of laws and procedures that many view as plaintiff friendly. One bulwark against blatant forum shopping is personal jurisdiction under the U.S.
New patent for SPIL drug ASPRUZYO SPRINKLE
Drug Patent Watch
DECEMBER 2, 2022
Annual Drug Patent Expirations for ASPRUZYO+SPRINKLE Aspruzyo Sprinkle is a drug marketed by Spil and is included in one NDA. It is available from one supplier. There is one patent…. The post New patent for SPIL drug ASPRUZYO SPRINKLE appeared first on DrugPatentWatch - Make Better Decisions.
Which pharmaceutical companies have the most SPCs in Finland?
Drug Patent Watch
DECEMBER 1, 2022
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Finland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Finland? appeared first on DrugPatentWatch - Make Better Decisions.
New patent for MIRUM drug LIVMARLI
Drug Patent Watch
DECEMBER 1, 2022
Annual Drug Patent Expirations for LIVMARLI Livmarli is a drug marketed by Mirum and is included in one NDA. There are three patents protecting this drug. This drug has one…. The post New patent for MIRUM drug LIVMARLI appeared first on DrugPatentWatch - Make Better Decisions.
Let's personalize your content